Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy

被引:39
|
作者
Suzuki, Hideaki [1 ]
Hashida, Koichi [1 ]
Khac-Hung Nguyen [1 ]
Hohchi, Nobusuke [1 ]
Katoh, Akiko [1 ]
Koizumi, Hiroki [1 ]
Ohbuchi, Toyoaki [1 ]
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
来源
LARYNGOSCOPE | 2012年 / 122卷 / 05期
关键词
Idiopathic sudden sensorineural hearing loss; intratympanic steroid administration; hyperbaric oxygen therapy; hearing outcome; Level of Evidence: 2b; DEXAMETHASONE; DEAFNESS;
D O I
10.1002/lary.23245
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The efficacy of intratympanic steroid administration was examined in comparison with hyperbaric oxygen (HBO) therapy in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). Study Design: Retrospective study. Methods: Two hundred seventy-six consecutive patients with ISSNHL (average hearing levels at 250, 500, 1,000, 2,000, and 4,000 Hz >= 40 dB; time from onset to treatment <= 30 days) were enrolled. All the patients were given intravenous hydrocortisone (400 mg/day) followed by tapered doses. In addition, 174 patients underwent HBO therapy (HBO group), and 102 patients received intratympanic dexamethasone injection (IT group). The hearing outcomes were evaluated by six indices; the cure rate, marked-recovery rate (percent of patients with hearing gains >= 30 dB), recovery rate (percent of patients with hearing gains >= 10 dB), hearing gain, hearing level after treatment, and hearing improvement rate compared to the unaffected contralateral ear. Results: There was no significant difference in the cure rate, marked-recovery rate, hearing gain, hearing level after treatment, or hearing improvement rate between the two groups; however, the recovery rate was significantly higher in the IT group than in the HBO group (79.4% vs. 68.4%; P = .048). Multiple logistic regression analysis also showed that patients in the IT group were significantly more likely to recover than those in the HBO group (odds ratio: 2.045; 95% confidence interval: 1.097-3.812; P = .024). Conclusions: Systemic plus intratympanic steroid administration is more effective than systemic steroids plus HBO therapy, and can be a useful first-choice treatment for ISSNHL.
引用
收藏
页码:1154 / 1157
页数:4
相关论文
共 50 条
  • [1] Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases
    Yalcin Alimoglu
    Ender Inci
    Deniz Tuna Edizer
    Alper Ozdilek
    Mehmet Aslan
    [J]. European Archives of Oto-Rhino-Laryngology, 2011, 268 : 1735 - 1741
  • [2] Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid plus hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases
    Alimoglu, Yalcin
    Inci, Ender
    Edizer, Deniz Tuna
    Ozdilek, Alper
    Aslan, Mehmet
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2011, 268 (12) : 1735 - 1741
  • [3] Comparison of Intratympanic Steroid and Hyperbaric Oxygen Salvage Therapy Hearing Outcomes in Idiopathic Sudden Sensorineural Hearing Loss: A Retrospective Study
    Ajduk, Jakov
    Pecek, Mirta
    Kelava, Iva
    Zaja, Roko
    Ries, Mihael
    Kosec, Andro
    [J]. EAR AND HEARING, 2023, 44 (04): : 894 - 899
  • [4] Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss
    Takeyuki Fujimura
    Hideaki Suzuki
    Teruo Shiomori
    Tsuyoshi Udaka
    Takanori Mori
    [J]. European Archives of Oto-Rhino-Laryngology, 2007, 264 : 861 - 866
  • [5] Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss
    Fujimura, Takeyuki
    Suzuki, Hideaki
    Shiomori, Teruo
    Udaka, Tsuyoshi
    Mori, Takanori
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2007, 264 (08) : 861 - 866
  • [6] Comparison of Intratympanic Steroid Injection, Hyperbaric Oxygen and Combination Therapy in Refractory Sudden Sensorineural Hearing Loss
    Yang, Chao-Hui
    Wu, Re-Wen
    Hwang, Chung-Feng
    [J]. OTOLOGY & NEUROTOLOGY, 2013, 34 (08) : 1411 - 1416
  • [7] Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy
    Bae, Seong-Cheon
    Noh, He-Il
    Jun, Beom-Cho
    Jeon, Eun-Ju
    Seo, Jae-Hyun
    Park, So-Young
    Kim, Jun-Kyu
    Lee, Dong-Hee
    Oh, Jeong-Hoon
    Park, Shi-Nae
    Yeo, Sang-Won
    [J]. ACTA OTO-LARYNGOLOGICA, 2013, 133 (05) : 428 - 433
  • [8] Comparison of Steroid Treatment with and without Hyperbaric Oxygen Therapy for Idiopathic Sudden Sensorineural Hearing Loss
    Yucel, Abitter
    Ozbugday, Yasar
    [J]. JOURNAL OF AUDIOLOGY AND OTOLOGY, 2020, 24 (03): : 127 - 132
  • [9] Oral and Intratympanic Steroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss
    Hara, Jared H.
    Zhang, Julia A.
    Gandhi, Krupa R.
    Flaherty, Anna
    Barber, Wayne
    Leung, Marcia A.
    Burgess, Lawrence P.
    [J]. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2018, 3 (02): : 73 - 77
  • [10] Clinical efficacy of hyperbaric oxygen therapy on idiopathic sudden sensorineural hearing loss
    Bagli, Bekir Selim
    [J]. UNDERSEA AND HYPERBARIC MEDICINE, 2020, 47 (01) : 51 - 56